Podcasts about Mash

"What we do in Mexico is my dream for Minnesota. We provide free spay neuter to both owned and street animals every single week." This episode is sponsored-in-part by Maddie's Fund and The Community Cat Clinic. In this international perspective episode, host Stacy LeBaron speaks with Maia Rumpho, founder of Pet Project Rescue, who turned a chance encounter with a street dog in Mexico into a binational animal welfare organization. Maia's journey began in 2007 during an engagement trip to Mexico, where rescuing a street dog sparked her understanding of the resource disparities between communities. What started as a dog-focused rescue evolved into Minnesota's only free TNR program, while maintaining weekly spay/neuter clinics in Mexico that serve as a model for comprehensive community animal care. Maia shares how her social work background shapes her approach to animal welfare, recognizing that effective programs must address barriers facing the people who care for community cats. Her organization removes financial obstacles that might force caregivers to choose between their own basic needs and helping animals. The conversation explores the striking differences between urban and rural cat populations in Minnesota, where urban colonies typically number 10 or fewer cats while rural areas often have 30 or more. Maia discusses the challenge of veterinary access in rural areas, where both distance and lack of feral cat experience among local veterinarians create significant barriers. The discussion highlights Maia's experience working in Mexico, where government support, animal control cooperation, and cross-organizational teamwork create an environment she wishes could be replicated in Minnesota. Her Mexico programs include weekly clinics serving 25 animals and annual three-day events handling 1,100-1,200 animals with remarkable efficiency. Maia's vision includes bringing MASH-style clinics to Minnesota, already piloting monthly Friday clinics in North Minneapolis that target the city's highest need area. This episode demonstrates how international experience can inform domestic programs and why collaboration across all sectors is essential for addressing community cat overpopulation. Press play now for: How a 2007 Mexico engagement trip sparked Minnesota's only free TNR program The dramatic scale difference: 30+ cat rural colonies vs. 10 or fewer urban populations Mexico's collaborative model with government support and skilled veterinarians Weekly clinics serving 25 animals and annual 1,100+ animal three-day events Why Minnesota procedures cost 4-6 times more than Mexico operations Adapting Mexican high-volume models for North Minneapolis communities The authorization system that provides flexibility for unexpected additional cats Strategic targeting of areas with highest need and lowest income brackets Why summer is optimal timing for TNR activities nationwide Resources mentioned: Pet Project Rescue website (https://petprojectrescue.com/) Pet Project Rescue Instagram: @PPR_mpls (https://www.instagram.com/ppr_mpls/) Pet Project Rescue Facebook page (https://www.facebook.com/PetProjectRescue/) Pet Project Rescue TNR Program (https://petprojectrescue.com/about/programs/trap-neuter-return-tnr/) Coco's Animal Welfare - Playa del Carmen, Mexico partner (https://cocosanimalwelfare.org) Rocco's Relief Foundation - Mexico City area partner (https://rrfmexico.org) MN SNAP - Minnesota Spay Neuter Assistance Program (https://mnsnap.org/) Contact: Info@PetProjectRescue.com Sponsor Links: Maddie's Fund (https://www.communitycatspodcast.com/maddies631) The Community Cat Clinic (https://www.communitycatspodcast.com/catclinicga) Follow & Review We'd love for you to follow us if you haven't yet. Click that purple '+' in the top right corner of your Apple Podcasts app. We'd love it even more if you could drop a review or 5-star rating over on Apple Podcasts(https://podcasts.apple.com/us/podcast/the-community-cats-podcast/id1125752101?mt=2). Select “Ratings and Reviews” and “Write a Review” then share a quick line with your favorite part of the episode. It only takes a second and it helps spread the word about the podcast.

Go to www.LearningLeader.com for full show notes This is brought to you by Insight Global. If you need to hire 1 person, hire a team of people, or transform your business through Talent or Technical Services, Insight Global's team of 30,000 people around the world have the hustle and grit to deliver. www.InsightGlobal.com/LearningLeader The Learning Leader Show with Ryan Hawk Guest: Jake Tapper is an award-winning broadcaster and chief Washington correspondent, currently anchoring The Lead with Jake Tapper every day on CNN. He's also the #1 New York Times best-selling author of 7 books, including The Outpost (which was later made into a movie), Original Sin, and most recently Race Against Terror. Notes: Be So Good They Can't Ignore You. Jake: I'm in control of how hard I work. It is our responsibility to work so hard that we become the obvious choice for the job or the promotion. Be So Good They Can't Ignore You. "I had to be so good that even though maybe on a broadcasting level I wouldn't be the number one pick... they had to give it to me." The one leadership skill that is massively important to develop… Don't insulate yourself with “yes” people. You have to have truth tellers in your life. Who are your foxhole friends? Who are the people who are willing and able to tell you the truth? Who are the ones who love you and care about you enough to let you know when you've messed up? Those people are gold. We all need them. Rejection: Dr. Seuss was rejected by 47 publishers. Rejection is part of life. You have to stay in the game for a chance to win it. Keep going. And nobody will give you a job to be nice. What value do you bring to a company? How will you make your boss's life better? You get hired to solve a problem, not because someone wants to be nice. Pinned tweet since 2017 – "To see what is in front of one's nose needs a constant struggle." -- George Orwell. A reminder to see obvious truths being obscured by spin or wishful thinking. "You Can Always Tell Them No" - Ted Koppel's crucial advice to young Jake about maintaining journalistic integrity and not compromising values for opportunities. This became a career-defining principle that Jake still follows 20 years later. The Jar Jar Binks Theory of Leadership - Successful leaders often remove critics from their inner circle, creating dangerous echo chambers. "Great people often achieve as much as they can to the point that they are able to remove from their inner circle anyone who tells them they're being an asshole or making a wrong decision." Constructive vs. Destructive Criticism - Jake learned to distinguish between useful feedback and personal attacks: "Very few of my critics are people that I actually care what they think... folks who understand I'm just trying to be a good faith operative here." Curiosity as Career Driver - Deep curiosity drove Jake from reading microfiche about MASH as a kid to investigating complex stories as an adult: "I find something interesting and I wanna find out everything I can about it." Rejection as Constant Reality - Even at his career peak, Jake faces daily rejection: "I get rejected every day... it doesn't matter that I've had New York Times bestsellers before... it's part of life." Humility Enables Learning - Accepting expertise gaps allows growth: "Having the humility to accept that I am not an expert on any particular thing... I'm a journalist, which means I try to be an expert on whatever I'm covering at that moment." Leadership Lessons From Powerful People The Inner Circle Problem: Leaders systematically remove critics until surrounded only by yes-people, creating dangerous blind spots. Jake witnessed this pattern with Joe Biden (surrounded by aides and family who weren't honest about his declining acuity) and across industries. The Solution: Intentionally maintain truth-tellers in your inner circle who care about you personally but will challenge you professionally. Creating Truth-Telling Environments: Jake encourages healthy disagreement with executive producers, acknowledges power imbalances that make criticism harder for junior staff, and creates indirect channels for feedback ("some people on the staff think..."). The Criticism Paradox: Public leaders face constant harsh criticism, making them naturally defensive. Understanding this context helps leaders distinguish between constructive feedback that improves performance versus personal attacks that serve no purpose. Following Curiosity Despite Opposition Jake's major works were all advised against by professionals: The Outpost (no military expertise) The Atlantic story of freeing a wrongly imprisoned man Biden book (started the day after the election, despite uncertainty) Key Insight: "Every single one of them, people were telling me not to do it... It's been following my curiosities even when people told me I'm not interested in that." The Hard Work Advantage: Jake couldn't compete on appearance or natural broadcasting ability, so he outworked everyone: broke stories constantly, used blogs when he couldn't get on air, and made himself impossible to ignore through sheer output. Dealing with Rejection Expect constant rejection even at a career peak Don't take rejection personally unless there's constructive feedback Use rejection as data, not judgment of worth Keep creating regardless of immediate acceptance The Wave Metaphor: Like Tom Hanks in Cast Away, timing the waves - "every code can be cracked" if you persist and find the right timing. Key Elements for Writers: Strong structure: "Act one, chase your hero up a tree. Act two: throw rocks at your hero. Act three, get your hero out of the tree." Good editor who pushes back - be willing to "kill your darlings" Life Philosophy The Acceleration Mindset: At 56, Jake is speeding up output: "I don't know how much longer I have this window where people are paying attention... relevance is ephemeral... when it leaves, it looks fucking brutal." For Young People: "So much of life is rejection... You cannot stop it... don't take it personally." Focus on developing skills and delivering value: "Nobody will give you a job to be nice... They'll do it because you have something they want." Time Sacrifice Awareness: Success requires acknowledging costs: "What I cried about is the stuff I missed that I wasn't there for because I was chasing a story or on assignment." Time Stamps: 02:46 Jake's Dedication to Influential Figures 05:05 Hot Mic Moment in Alaska 06:59 Preparing for Big Interviews & When to Follow Up 09:01 Dealing with Criticism 12:07 The Story Behind Jake's Pinned Tweet 13:48 Race Against Terror: The New Book 18:29 Balancing Multiple Roles 20:47 Chasing Your Own Curiosity  23:58 Sacrifices for Career Success 29:00 The Importance of Humility in Leadership 31:08 Surrounding Yourself with Truth Tellers 34:18 Healthy Tension in Team Dynamics 37:15 Understanding the Pressure on Public Figures 40:09 Empathy in Leadership 45:17 Balancing Career and Family 49:00 Advice for Aspiring Journalists and Writers 52:01 The Reality of Rejection and Hard Work 57:26 The Importance of Structure and Editing in Writing 01:01:16 End of the Podcast Club

Medverkande i detta avsnitt är: Fredrik, Poki, Danny och kort gästspel från Ice!I detta avsnitt bjuder på samtal om spel, anime och dvärgbesök - allt i ett trevligt sällskap!Spel som tas upp:Hell is Us,LEGO Voyagers,Metal Gear Solid Delta: Snake Eater,Anno 117: Pax Romana (demo),South of Midnight,Film/TV som tas upp:The Fragrant Flower Blooms with Dignity (Anime), Apocalypse Bringer Mynoghra (Anime),Min vän Mac,M*A*S*H,Övrigt som tas upp:Denna gång har vi en Q & A fråga som ställer den simpla frågan: Vilka spel har vi i vår topp 10 lista över bästa spel NÅGONSIN! Enkelt eller hur

CBS had a slew of hits in the early 70s, including a wartime comedy called M*A*S*H.  CBS went to the wartime well again in 1973 with this comedy about a battalion of primarily African-American soldiers in France during World War II.  As bad as the ratings were, that may not have been what got the show cancelled so quickly.  It's not good when your lead and a supporting cast member were arrested during the show's brief run.

Download for non pitched version

100 years ago this year, celebrated director Robert Altman was born. To celebrate his legacy and influence on film, the Criterion Channel has launched a new September series, Directed by Robert Altman. The series includes films like "The Player," "The Long Goodbye," and "MASH." Sean Fennessey, co-host of "The Big Picture" and curator of the Criterion series, joins to discuss. Plus, callers share their favorite Robert Altman movies.

MASH debuted on this day and Nick Cannon talks about why he had 12 kids. 

Hour 2 of the Tuesday Bob Rose Show, on some left-wing pundits that are shocked by the assassination of Charlie Kirk, and the MASH character of crazy Klinger to the reality of today's sex change operations. And all the morning's breaking news stories for 9-16-2025.

Jeff & Ryan welcome Greg Izay to MASH Matters! Greg's mother, Connie, was the on-set medical technical advisor on M*A*S*H. We remember Connie through Greg's stories about her beginnings in the industry, how she helped actors look like real surgeons, her long career behind the scenes, and her brief moments ON screen. Plus - the M*A*S*H/Smokey & the Bandit crossover you've been waiting for!   Support the podcast on Patreon and buy merch at the MASH Matters store   For show notes, episodes, recipes, bios, and more visit our website.  

Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let's dive into the latest updates impacting clinicians and healthcare providers like you! Interested in a more traditional, text rundown? Check out the HCPFive! Top 5 Healthcare Headlines for September 5-September 14, 2025: 1. FDA Removes Sparsentan (Filspari) Advisory Committee Meeting for FSGS sNDA The FDA determined no advisory committee is needed for sparsentan's sNDA in FSGS, which remains under review with a January 2026 decision date. 2. Intercept Voluntarily Withdraws Obeticholic Acid (Ocaliva) for PBC From US Market Intercept will withdraw obeticholic acid from the US PBC market after an FDA request and related clinical trial holds. 3. FDA Accepts FibroScan Letter of Intent for Surrogate Endpoint in MASH Trials The FDA accepted a proposal to qualify FibroScan liver stiffness measurement as a surrogate endpoint for MASH trials, supported by multiple industry partners. 4. FDA Clears IND Application for EGEN-2784, a Genetically Engineered Pig Kidney, for ESKD eGenesis received FDA clearance to begin clinical testing of a genetically engineered porcine kidney transplant in patients with ESKD. 5. First in Class Cat, Birch Allergen Blockers Succeed in Phase 3 Trials Regeneron reported phase 3 success for novel allergen-blocking antibodies targeting cat and birch allergies, with confirmatory trials planned.

Isaac thinks it's a pregnancy craving, but we try Orlena's pickle recipe for Mash it Up Monday!

M*A*S*H was a Robert Altman directed 1970 Oscar nominee for Best Picture. What war was depicted in the move M*A*S*H? Play. Share. Listen with actor Fred Grandy. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Paul Linke and I discuss his one man shows; how his eulogy for his first wife turned into a one man play on HBO; how his second wife inspired his second show and his friendship with Charles Nelson Reilly his third; his new show, The Summer I Got Old; watching Kate Smith and Howdy Doody on an early TV; his love of the Doors turns into a performance piece based on "The End" at USC; appearing in The Baby Makers with Barbara Hershey; hosting, acting in and promoting The Golden Theater Festival; hosting the 1974 Christmas Seals Telethon; being a good eulogist working with Jackie Gleason & Lucille Ball; going to the Last Waltz; 60's music; his recurring role on Happy Days; Henry Winkler and Johnny Depp having the same aura; appearing with Alan Alda in a scene on MASH; Alda's technique and Michael Richards; slam dancing on CHiPS; the MAIT Team episode; seeing Timothy Leary's ashes; Keith Richards; being on The Mike Douglas Show; his role in Motel Hell; Elaine Joyce and JD Salinger; appearing on Supertrain and Just Men with Betty White; his 25 year friendship with John Ritter; and how his shows require a lot of adrenaline and make him crash afterwards

The FDA has endorsed vibration-controlled transient elastography as a surrogate endpoint for MASH trials, marking the first non-invasive alternative to liver biopsy. A Japanese cohort study linked breakfast skipping and late dinners to higher fracture risk, with combined habits raising risk by nearly 25%. Finally, a global meta-analysis suggests shingles vaccination reduces major cardiovascular events by ~16–18%, though most evidence is observational.

Send us a textThis discussion on ways to improve MASH patient management comes from the early July roundtable on "Major Issues of the First Six Months of 2025." As a reminder, that roundtable included the three co-hosts (Louise, Jörn Schattenberg and Roger Green) Roger drives this conversation, focusing on two very different, yet very important issues: the first is the increasing dynamism of the in-office scanning market, with leader Echosens developing new products and services, while companies like e-Scopics, Sonic Incytes, and Mindray (Hepatus) are introducing new devices with competing profiles. Roger discusses the idea that some scanners keep all data resident in the machine, while others send it immediately to the cloud. Louise suggests that while we should welcome any reliable scanning device to the market, Echosens has a significant advantage in terms of data richness and depth when compared to all competitors. (NOTE: This benefit became clearer when Echosens submitted a Letter of Intent to the FDA to qualify liver stiffness measurement (LSM) using VCTE, as found in FibroScan, as a reasonably likely surrogate endpoint in clinical trials for MASH.Separately, he lists some concerns about how the Trump Administration's focus on cutting services to the poor, coupled with Robert F. Kennedy Jr.'s distrust of pharmaceuticals and mainstream health research, might limit the number of Americans with access to healthcare and the kinds of care they can access. At the end of this conversation, Roger asks Jörn and Louise what they consider major issues for the next six months.

 The Great Eight – Question-by-Question Breakdown:Best Coaching Advice Ever Received Let go of the “pure coaching” textbook ideal. Trust your gut—bring more of yourself into the session. Coaching isn't about doing it “right”; it's about making connection relevant. What He's Still Improving Balancing being the expert with staying in inquiry. Constantly evaluates post-session notes to spot assumptions and adjust. Always working to honor what the client needs over what he thinks they need. Most Outrageous Thing in a Session Called out a highly respected (but feared) surgeon directly: “You are not succeeding.” Blunt honesty is his superpower—used only after trust is firmly established. What Still Makes Him Uncomfortable Sitting in the discomfort with the client and knowing change takes time. Coming from a profession (anesthesiology) designed to eliminate pain, this is a big shift. Advice to Doctors Considering Coaching Coaching skills make you a better clinician, parent, friend, human. But the mindset shift—from answer-giver to space-holder—is massive. Recommends shadowing a coach or having a coach before training. What He's Had to Conquer His deep experience and diagnostic mindset often push him to “solve.” Coaching demands restraint, presence, and ongoing self-awareness. Journaling after sessions helps him stay grounded and reflective. How He Uses AI Early days. Uses it to analyze patterns in notes or brainstorm. No direct client interaction with AI yet. Still values the human connection. What He's Learned About Himself Through Coaching Coaching made him a better teacher, dad, spouse, and friend. Self-awareness led to values-driven change. His coaching benefits him as much as his clients—a quiet reminder that reflection is a two-way gift.  ☕ Fun StuffDream Job Origin Story?He wanted to be Hawkeye Pierce from MASH*—not a joke. He secretly watched the show at night and fell in love with the idea of being the revered, wisecracking, skillful doctor.Spoiler: He never dated a nurse.

A pregnant woman who pulled into a McDonald's car park after feeling faint has been forced to pay a £100 fine for overstaying the time limit.The mother-of-four stopped at the fast-food restaurant in Orbital Park, Ashford, as she feared she would pass out at the wheel.Also in today's podcast, we've got more reaction to the news the University of Kent and the University of Greenwich are going to merge to form one “super uni”.We've spoken to university bosses who haven't ruled out redundancies, and the Canterbury MP who's unhappy about how the news broke.Floral tributes and touching messages have been placed at a school as heartbroken staff, pupils, and parents mourn the loss of a much-loved teacher.Concerned colleagues went to the 45-year-old's home on Monday, after she did not turn up for work and failed to call in sick.A Reform UK councillor has launched a campaign to try and prevent drink spiking after he was targeted at a pub in Ashford.Dean Burns is thought to have had his beer tampered with while out with friends and was left virtually unconscious.And a former boxing coach is hoping to launch a pie and mash empire after opening his first east London-style shop to much fanfare.You can hear from the owner of Julian's Pie and Mash in the Forum Shopping Centre in Sittingbourne which opened last week. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Welcome to Week In Geek Wednesday for our quick-hits segment of entertainment and interesting bits of internet debris for you... the people! In this episode, we talk about fantasy football teams, the return of AJ Lee to WWE, college move-in day, and Katee Sackhoff's troubles after Bo Katan!   FULL VIDEO EPISODES! That's right folks, you can see our bright smiling idiotic faces in full color on our YouTube channel. Full episodes available as well as clips.   LINKS OF INTEREST: - Unfortunate story around Katie Sackhoff's post-Mando experience - Here's the YouTube clip from The Sackhoff Show   ...AND ANOTHER THING: The Man They Call Tim suggests watching “What Do You Want To Talk About With Cody Rhodes" with guest Bruce Pritchard on YouTube Uncle Todd suggests watching "M*A*S*H" streaming on Disney+   FOLLOW US ON THE SOCIAL MEDIAS: Facebook - http://facebook.com/freerangeidiocy Instagram - http://instagram.com/freerangeidiocy YouTube - http://youtube.com/@freerangeidiocy

Molecular biologist and Nobel Prize winner David Baltimore made foundational contributions to the biopharma industry and was the essential figure behind such research institutions as the Whitehead Institute for Biomedical Research and the Broad Institute. On the latest BioCentury This Week podcast, BioCentury's analysts discuss the legacy of Baltimore, who passed away this past weekend at 87.The analysts also discuss Atlas Venture's new $400 million opportunity fund, the clinical development pipelines for metabolic-associated steatohepatitis (MASH) and chronic urticaria, and late-stage atopic dermatitis data from Sanofi. This episode of BioCentury This Week is sponsored by IQVIA Biotech.View full story: https://www.biocentury.com/article/656942#biotech #biopharma #DavidBaltimore #ReverseTranscriptase #MASH #Rezdiffra #GLP1 #ChronicUrticaria #Dupixent00:01 - Sponsor Message: IQVIA Biotech03:19 - Remembering David Baltimore06:20 - Atlas' New Opportunity Fund09:16 - The Growing MASH Pipeline15:57 - Sanofi's Atopic Dermatitis Data18:51 - Exploring Chronic Urticaria TreatmentsTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Send us a textThis discussion on ways to improve MASH patient management comes from the early July roundtable on "Major Issues of the First Six Months of 2025." As a reminder, that roundtable included the three co-hosts (Louise, Jörn Schattenberg and Roger Green) Louise drives this conversation based on two related issues she sees emerging: (i) increasing opportunities for motivated patients to manage their own health and (ii) managing the total patient in an environment where people may be taking incretin agonists as if they are consumer drugs. With increased access to scanning, providers can monitor patients (and patients can self-monitor) more closely. However, some of the issues a provider might find are tricky: patients who undertake what Louise describes as "the sneaky areas patients think are normal, but are probably contributing to disease" due to miseducation or no education on healthy eating and lifestyle, or patients purchasing and using incretin agonists through consumer channels, but possibly at subtherapeutic doses. Vigilance and probing are key here, but health systems will need to train more people on the types of probing that uncover underlying issues and behaviors that patients mistakenly believe to be healthy. The discussion also extends to the role of NITs in diagnosis and patient management, and how providers need to shift the paradigm away from describing a patient by fibrosis stage and instead focus on the amount of fat in the liver and its overall suppleness.

Send us a textLast month, The Lancet posted online an article from Stine Johansen, Fredrik Åberg, Emmanuel Tsochatzis and Aleksander Krag, titled "Screening for Advanced Liver Disease." The article aims to update the Wilson and Jungner criteria, initially developed in 1960, to address modern needs and issues. In this conversation, Professor Krag and Dr. Johansen join Roger Green to discuss their article. There are many nuances and high points to cover in this thoughtful, fairly lengthy conversation, but one key point is that screening a mass population for HCC or cirrhosis has an entirely different set of issues and criteria compared to the screening usually discussed on this podcast, which involves identifying a population at increased risk for MASLD or MASH and screening them. Also, healthcare is far more expensive than it was in 1960 with a plethora of high-cost ways to diagnose, treat and manage patients.As a result, the authors started with the 10 Wilson and Jungner criteria and added eight more. During this conversation, Stine emphasizes the need for a comprehensive clinical trial on this issue, and all panelists agree that LiverAIM is likely to serve as the study.

Kayla texted in to ask if we'd ever had carrots and honey, so we made it our Mash it Up Monday combo!

05.09.25 Pt 2 - Gareth is joined by Mash and Ben for a hilarious deep dive into some questionable bathroom habits — including whether it's humanly possible to sneeze and use the toilet at the same time. The trio then debates double standards between men and women, and wrap things up by asking: when someone says “let me finish,” does it actually mean they're talking nonsense? The Real Network

Send us a text00:00:00 - Surf's Up: Season 6 Episode 13 Louise Campbell, Jörn Schattenberg and Roger Green continue their discussion of some major issues from earlier this year, while co-authors Aleksander Krag and Stine Johanset join Roger to discuss their recent publication in The Lancet, titled "Screening for Advanced Liver Disease." 00:04:45 - Major Issues of the First Six Months: Integrated Patient ManagementLouise drives this conversation based on two related issues she sees emerging: (i) increasing opportunities for motivated patients to manage their own health and (ii) managing the total patient in an environment where people may be taking incretin agonists as if they are consumer drugs. With increased access to scanning, providers can monitor patients (and patients can self-monitor) more closely. However, some of the issues a provider might find are tricky: patients who undertake what Louise describes as "the sneaky areas patients think are normal, but are probably contributing to disease" due to miseducation or no education on healthy eating and lifestyle, or patients purchasing and using incretin agonists through consumer channels, but possibly at subtherapeutic doses. Vigilance and probing are key here, but health systems will need to train more people on the types of probing that uncover underlying issues and behaviors that patients mistakenly believe to be healthy. 00:21:02 - Newsmakers: Aleksander Krag and Stine Johansen discuss Screening for Advanced Liver DiseaseLast month, The Lancet posted online an article from Stine Johansen, Fredrik Åberg, Emmanuel Tsochatzis and Aleksander Krag, titled "Screening for Advanced Liver Disease." The article aims to update the Wilson and Jungner criteria, originally developed in 1960, to address modern needs and issues. In this conversation, Professor Krag and Dr. Johansen join Roger Green to discuss their article. There are many nuances and high points to cover in this thoughtful, fairly lengthy conversation, but the key point is that screening a mass population for HCC or cirrhosis has an entirely different set of issues and criteria compared to the screening usually discussed on this podcast, which involves identifying a population at increased risk for MASLD or MASH and screening them. 00:54:42 - Major Issues of the First Six Months: Changes in US Health Policy and Potential for Dynamism in the In-Office Scanning Market Roger drives this conversation, focusing on two very different, yet very important issues: the first is the increasing dynamism of the in-office scanning market, with leader Echosens developing new products and services, while companies like e-Scopics, Sonic Incytes, and Mindray (Hepatus) are introducing new devices with competing profiles. Roger discusses the idea that some scanners keep all data resident in the machine, while others send it immediately to the cloud. Louise suggests that we should welcome any reliable scanning device to the market. Separately, he lists some concerns about how the Trump Administration's focus on cutting services to the poor, coupled with Robert F. Kennedy Jr.'s distrust of pharmaceuticals and mainstream health research, might limit the number of Americans with access to healthcare and the kinds of care they can access. At the end of this conversation, Roger asks Jörn and Louise what they consider major issues for the next six months.01:11:40 - Business Report and Wrap-Up

Send us a textInteresting things about the distillery:Ryan is from the military and Holly worked with airlinesRyan is also a glassblowerNames of the bottles are based on glassblowing itemsDidymium is a purple filtering glass that glassblowers wear to protect their eyes, filtering out all the other bottles on the shelfThe Gaffer collection is their limited release, and a Gaffer is the head glassblowerThe First batch just released includes 20% Amaranth which is similar to wheatVERY Small production.  You can join the founders club on their website to help them grow and purchase a distilleryOur Bottle: Didymium Bourbon Batch:Batch 1: Release Nov. 2024. Mash bill 80% purple corn, 15% rye, 5% malt. Barrel Char 3Batch 2: Release Dec. 2024. Mash bill 80% purple corn, 5% rye, 5% malt. Barrel Char 3Batch 3: Release Mar. 2025. Mash bill 75% purple corn, 15% rye, 10% malt. Barrel Char 3Batch 4: Release Jun. 2025. Mash bill 75% purple corn, 15% rye, 10% malt. Barrel Char 4Pipe Pairings: Dunhill flakeCocktails:Support the showWebsite:www.whiskeychaserspod.comFacebook:https://www.facebook.com/whiskeychaserspodcastInsta:https://www.instagram.com/whiskeychaserspodcast/TikTok:https://www.tiktok.com/@whiskeychaserspodcastThanks For Listening! Tell a Friend!

Send us a textKey Opinion Leaders Manal Abdelmalek, Naim Alkhouri, Scott Isaacs and Zobair Younossi join Roger Green to discuss the FDA's approval of semaglutide for patients with non-cirrhotic MASH. This conversation centers on the roles that new technologies and an expanded APP population will play in MASLD and MASH management in the US, and concludes by exploring how care might look different 12 months from now, and then in subsequent years. As panelists identify some of the changes they foresee if we are to manage the tsunami of undiagnosed MASLD patients, many comments touch on themes discussed earlier in this episode. A couple are unique. Zobair and Scott discuss the increased role that artificial intelligence and big data analytics will play in identifying high-risk patients and improving clinical pathways. Additionally, Zobair notes that we must remember that the vast majority of MASLD patients will never develop MASH. Manal foresees a more sophisticated approach to selecting pharmacotherapies as prescribers have a broader set of options, each with its own benefits and drawbacks. Scott anticipates a "paradigm shift" in which endocrinologists view MASH similarly to how they view retinopathy, neuropathy and retinopathy. Naim suggests that one year will not look tremendously different from today, but that five years from now will be an entirely different picture, which he describes in some detail. 

ATTENTION! This is an audio recording of the latest MASH Matters video livestream. We strongly encourage you to WATCH this episode on YouTube to see Jeff & Ryan's ugly mugs (faces), pretty mugs (cups), old TV clips, and a surprise appearance by Walter Eugene Patrick! This livestream aired live on August 31, 2025. CLICK HERE TO WATCH THE LIVESTREAM REPLAY ON YOUTUBE

What kinds of things do neutron stars do? They can smash into each other, producing bright flashes of radiation and strong ripples in spacetime that can be detected across the universe! Or, a neutron star can just be sitting there, and its magnetic field might suddenly shift and produce a dramatic burst of radio waves! But mainly, neutron stars are super-dense and super-complicated, giving us a probe of fundamental physics in its most extreme limits. Dr. Wen-Fai Fong tells us all about how we can learn more!

Join us as we recap this classic 1970's sitcom. There's tons of fun trivia, discussion of the biggest pop culture news that dropped on the day we recorded this podcast and a discussion of Cheers without Sam and MASH with Hawkeye. We also mention: The Love Boat, Fantasy Island, Lucille Ball, Frasier and...Seinfeld!

THE BEST HUNGER GAMES MOVIE?! The Hunger Games: Catching Fire Full Movie Reaction Watch Along:   / thereelrejects   Get your New Customer offer + 3-month Unlimited wireless plan for just 15 bucks a month at https://www.mintmobile.com/REJECTS Support The Channel By Getting Some REEL REJECTS Aparrel! https://www.rejectnationshop.com/ With The Hunger Games: Sunrise on the Reaping on the horizon, Aaron & Andrew continue their journey giving their The Hunger Games: Catching Fire Reaction, Recap, Analysis, & Spoiler Review! The Hunger Games: Catching Fire (2013), directed by Francis Lawrence, continues the epic dystopian saga based on Suzanne Collins' bestselling novels. Jennifer Lawrence (Silver Linings Playbook, X-Men: First Class) returns as Katniss Everdeen, who finds herself once again thrust into the deadly Hunger Games arena after her defiance in the previous installment inspires rebellion across Panem. Josh Hutcherson (Bridge to Terabithia, The Kids Are All Right) stars as Peeta Mellark, her fellow victor and partner in survival, while Liam Hemsworth (The Last Song, Independence Day: Resurgence) plays Gale Hawthorne, torn between loyalty and revolution. Donald Sutherland (The Italian Job, MAS*H) returns as the chilling President Snow, joined by Philip Seymour Hoffman (Capote, The Master) as the sly new Gamemaker, Plutarch Heavensbee. Supporting performances include Woody Harrelson (True Detective, Zombieland) as Haymitch, Elizabeth Banks (Pitch Perfect, The Lego Movie) as Effie Trinket, and Stanley Tucci (The Devil Wears Prada, Spotlight) as the flamboyant Caesar Flickerman. From Katniss and Peeta's unforgettable Victory Tour to the shocking Quarter Quell reveal, the film builds to one of the franchise's most iconic cliffhangers. With stunning visuals, political intrigue, and the unforgettable “girl on fire” moments, Catching Fire set the stage for the Mockingjay films while cementing Katniss Everdeen as one of cinema's most enduring heroes. Join Aaron Alexander & Andrew Gordon as they react, review, and break down the most emotional, action-packed, and game-changing moments of this blockbuster sequel. Follow Aaron On Instagram: https://www.instagram.com/therealaaronalexander/?hl=en Follow Andrew Gordon on Socials:  YouTube: https://www.youtube.com/@MovieSource Instagram:  https://www.instagram.com/agor711/?hl=en Twitter:  https://twitter.com/Agor711 Intense Suspense by Audionautix is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/... Support The Channel By Getting Some REEL REJECTS Apparel! https://www.rejectnationshop.com/ Follow Us On Socials:  Instagram: https://www.instagram.com/reelrejects/  Tik-Tok: https://www.tiktok.com/@reelrejects?lang=en Twitter: https://x.com/reelrejects Facebook: https://www.facebook.com/TheReelRejects/ Music Used In Ad:  Hat the Jazz by Twin Musicom is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Happy Alley by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/... POWERED BY @GFUEL Visit https://gfuel.ly/3wD5Ygo and use code REJECTNATION for 20% off select tubs!! Head Editor: https://www.instagram.com/praperhq/?hl=en Co-Editor: Greg Alba Co-Editor: John Humphrey Music In Video: Airport Lounge - Disco Ultralounge by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Ask Us A QUESTION On CAMEO: https://www.cameo.com/thereelrejects Follow TheReelRejects On FACEBOOK, TWITTER, & INSTAGRAM:  FB:  https://www.facebook.com/TheReelRejects/ INSTAGRAM:  https://www.instagram.com/reelrejects/ TWITTER:  https://twitter.com/thereelrejects Follow GREG ON INSTAGRAM & TWITTER: INSTAGRAM:  https://www.instagram.com/thegregalba/ TWITTER:  https://twitter.com/thegregalba Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textKey Opinion Leaders Manal Abdelmalek, Naim Alkhouri, Scott Isaacs and Zobair Younossi join Roger Green to discuss the FDA's approval of semaglutide for patients with non-cirrhotic MASH. This conversation focuses on how the US healthcare system must adapt to handle the growing number of MASH and MASLD patients who might seek treatment, given likely increases in publicity and education.The conversation starts with a focus on the implications of semaglutide approval for hepatologists. Naim states that many hepatologists are currently uncomfortable managing patients on GLP-1 agonists. This will need to change. Manal points out that providers must check for cirrhosis when testing for MASH and understand how to respond accordingly. An increase in the number of providers having access to in-office scanning devices will facilitate this process.Zobair shifts to a larger point:  even if all related specialists integrate MASH into their practices, the actual patient care demand will require alternative pathways in which the responsibility for patient care will rest with specialist APPs. The number of APPs necessary to handle this load and trained to do so does not currently exist in the US. Increased APP training must, and will, become an area for increased investment and focus.After Naim Alkhouri describes some of the differences between resmetirom and semaglutide in terms of practical treatment decisions, the discussion focuses on why MASLD and MASH will create unique challenges for hepatology practices. Manal views the issue as a matter of time; practices cannot absorb large numbers of new, non-urgent patients. Naim suggests that the real issue is the business question: specialists today do not profit simply from treating patients. Zobair agrees with Naim and notes that the challenge is not unique to hepatology. He expresses the hope that AI and efficient database management will make it easier to target, screen, diagnose and treat patients...given sufficient providers (mostly APPs) to treat them. 

Send us a textKey Opinion Leaders Manal Abdelmalek, Naim Alkhouri, Scott Isaacs and Zobair Younossi join Roger Green to discuss  FDA's approval of semaglutide for patients with non-cirrhotic MASH. This conversation focuses on benefits for patients and ways that having two drugs with different modes of action will change pharmacotherapy choices.This conversation starts with the group describing the sense of "enthusiasm" and "fulfillment" hepatology drug developers feel to see two drugs approved in the US and many other major changes to come (more drug approvals, FDA acceptance of a path to approval that is not based on liver biopsy). One interesting takeaway is that while the approval of semaglutide will likely change the number of patients treated with MASH pharmacotherapy, the greater impact of this approval will be on public awareness of MASH and the accompanying demand for treatment. In terms of actual drug use, the first major change will come among patients living with obesity but not Type 2 diabetes. Most of these patients previously saw their semaglutide prescriptions rejected for payment by health insurers. However, many of these patients will be living with MASH, and they are likely to see their prescriptions approved. Instead, the largest impact may involve increased education and awareness. Scott pointed out that endocrinologists, who frequently prescribe incretin agonists, will have reason to learn how to diagnose and manage MASH in patients they already treat. Zobair noted that an array of companies, starting with pharmaceutical manufacturers and scanning companies, will dramatically increase investments in prescriber and patient education. Another important benefit may come in terms of coverage. Scott points out that most patients living with obesity but not diabetes are unlikely to have their semaglutide prescriptions covered by commercial insurers. Those living with non-cirrhotic MASH are likely to have semaglutide covered. A separate but related point: Naim reports that ~30% of the MASH patients he sees are taking an incretin agonist at the time of initial visit.

Hollywood actor Alan Alda has devoted his life to science, by taking his acting and communication skills off the screen and into the laboratory. Alan grew up in a show business family and spent his childhood touring with a burlesque show run by his parents.He eventually made a name for himself in showbiz, becoming well-known and much-loved for his performances in M.A.S.H. and The West Wing, as well as his roles in many Hollywood films.Alan is also famous for his love of science.He wrote Dear Albert for the stage, based on the love letters of Albert Einstein, which reveal Einstein as a beautifully passionate man.Alan has used his acting for the good of science by teaching communication skills to scientists so they might make their work better known and better understood.Further informationThis interview was first broadcast in December 2016.2025 update:  Alan has been diagnosed with Parkinson's disease, but he says he's managing it well.  Alan is still working occasionally, most recently in the TV remake of his 1981 film ‘The Four Seasons'.You can read all about the Conversations origin story on the ABC News website.This episode of Conversations explores science, science communication, MASH, television, Hollywood, silver screen, acting, show biz families, family business, Vietnam, origin stories, memoir.To binge even more great episodes of the Conversations podcast with Richard Fidler and Sarah Kanowski go the ABC listen app (Australia) or wherever you get your podcasts. There you'll find hundreds of the best thought-provoking interviews with authors, writers, artists, politicians, psychologists, musicians, and celebrities.

Hollywood actor Alan Alda has devoted his life to science, by taking his acting and communication skills off the screen and into the laboratory. Alan grew up in a show business family and spent his childhood touring with a burlesque show run by his parents.He eventually made a name for himself in showbiz, becoming well-known and much-loved for his performances in M.A.S.H. and The West Wing, as well as his roles in many Hollywood films.Alan is also famous for his love of science.He wrote Dear Albert for the stage, based on the love letters of Albert Einstein, which reveal Einstein as a beautifully passionate man.Alan has used his acting for the good of science by teaching communication skills to scientists so they might make their work better known and better understood.Further informationThis interview was first broadcast in December 2016.2025 update:  Alan has been diagnosed with Parkinson's disease, but he says he's managing it well.  Alan is still working occasionally, most recently in the TV remake of his 1981 film ‘The Four Seasons'.You can read all about the Conversations origin story on the ABC News website.This episode of Conversations explores science, science communication, MASH, television, Hollywood, silver screen, acting, show biz families, family business, Vietnam, origin stories, memoir.To binge even more great episodes of the Conversations podcast with Richard Fidler and Sarah Kanowski go the ABC listen app (Australia) or wherever you get your podcasts. There you'll find hundreds of the best thought-provoking interviews with authors, writers, artists, politicians, psychologists, musicians, and celebrities.

Hollywood actor Alan Alda has devoted his life to science, by taking his acting and communication skills off the screen and into the laboratory. Alan grew up in a show business family and spent his childhood touring with a burlesque show run by his parents.He eventually made a name for himself in showbiz, becoming well-known and much-loved for his performances in M.A.S.H. and The West Wing, as well as his roles in many Hollywood films.Alan is also famous for his love of science.He wrote Dear Albert for the stage, based on the love letters of Albert Einstein, which reveal Einstein as a beautifully passionate man.Alan has used his acting for the good of science by teaching communication skills to scientists so they might make their work better known and better understood.Further informationThis interview was first broadcast in December 2016.2025 update:  Alan has been diagnosed with Parkinson's disease, but he says he's managing it well.  Alan is still working occasionally, most recently in the TV remake of his 1981 film ‘The Four Seasons'.You can read all about the Conversations origin story on the ABC News website.This episode of Conversations explores science, science communication, MASH, television, Hollywood, silver screen, acting, show biz families, family business, Vietnam, origin stories, memoir.To binge even more great episodes of the Conversations podcast with Richard Fidler and Sarah Kanowski go the ABC listen app (Australia) or wherever you get your podcasts. There you'll find hundreds of the best thought-provoking interviews with authors, writers, artists, politicians, psychologists, musicians, and celebrities.

Tommy Ruben joined me to discuss the closed knit cast of CPO Sharkey; growing up in Larchont, NY and his dad working for Sgt. Bilko; his dad Aaron, writing for Fred Allen, Milton Berle, Sid Caesar, The Andy Griffith Show and creating Gomer Pyle USMC; Don Rickles getting booed on Comic Relief; Sharkey's scripts scripts had ad-libs written in; being a class clown; guest starring on MASH; going to the Oakwood School; his dad''s film, The Comic; his father liked to build sitcoms around someone; creating CPO Sharkey; Polish jokes got the most letters; his first scene; episodes focusing on his character; the Johnny Carson incident and how has dad was mad; NBC wasn't all in on Don; Bob Newhart; his brother writing the punk rock episode; appearing in More American Graffiti with Cindy Williams; the difference in Drew Barrymore and James garner's acting methods; appearing and writing and episodes of The Stockard Channing Show; Rhonda Bates; being in his brothers movies; almost getting The Hardy Boys Show; and studying photography at the School of Visual Arts.

This week Megan and Evan took in director Rachel Abigail Holder's romantic drama LOVE, BROOKLYN (2:00), starring André Holland, Nicole Beharie, and DeWanda Wise. Short version: They liked it, with Megan revisiting it after seeing it at Sundance earlier this year. Next, Dave joins them for A LITTLE PRAYER (28:09), a quiet and understated Southern family drama from writer-director Angus MacLachlan, starring David Strathairn, Jane Lavy, and Celia Weston. Two of the three of us thought it was really well done, and one of us had hoped to like it more than they did. Such is life. Over on Patreon, we talk about Robert Altman's M*A*S*H, which turns 55 this year.

The FDA has granted accelerated approval to semaglutide (Wegovy) as the first drug for metabolic dysfunction–associated steatohepatitis (MASH), showing significant improvements in liver health and weight loss in the phase 3 ESSENCE trial. A systematic review of acetaminophen use in pregnancy found potential risks with long-term or frequent use but confirmed short-term, low-dose use remains appropriate when needed. Finally, an AI model integrating MRI, biomarkers, and clinical data improved prediction of knee osteoarthritis progression, enhancing physician accuracy and suggesting future support for earlier, personalized interventions.

"If you love cats, you should be concerned about trying to help bring those numbers down so animals don't suffer because this is why we do this. We don't want animals suffering, having unwanted litters of cats and having to have them suffer." This episode is sponsored-in-part by Maddie's Fund and 6 Degrees of Cats. In this powerful episode, host Stacy LeBaron sits down with Cathy Bissell, founder of Bissell Pet Foundation, who has revolutionized animal welfare through innovative programs reaching over 6,000 shelters across 49 states. From her unexpected entry into animal welfare during Hurricane Katrina to creating the nation's largest funded adoption event, Cathy's journey demonstrates how strategic thinking and passionate commitment can create systemic change. Her foundation has impacted nearly one million pets since 2011, but it's her latest initiative that's truly disrupting the industry. Cathy shares the incredible success of her groundbreaking "Fix the Future" program, launched in 2023 to address the veterinary care access crisis. In just under 18 months, this free spay/neuter initiative has sterilized 138,000 animals across 27 states, with an astounding 86,963 of those being cats. Through a network of 385 high-volume, high-quality relief veterinarians, the program is tackling overpopulation at its source while keeping costs remarkably low at just $35 per surgery. Cathy discusses the challenges of scaling this model, the importance of treating every animal that comes through their doors, and why she believes this "disruptor program" is essential for breaking down cost barriers that prevent people from accessing veterinary care. Whether you're working in a small grassroots rescue or leading a major shelter, this episode provides invaluable insights into creating sustainable, scalable solutions that address root causes rather than just symptoms. Cathy's emphasis on collaboration, her honest discussion about learning from mistakes (including a powerful story about declawing), and her practical advice for getting started at any age will inspire listeners to think bigger about their impact and consider how they can contribute to solving the access to care crisis in their own communities. Press play now for: Cathy's unexpected journey from Hurricane Katrina volunteer to founding a major animal welfare foundation The evolution from disaster response to adoption events to addressing systemic access to care challenges Incredible statistics: 138,000 spay/neuter surgeries in 18 months with 86,963 cats across 27 states How the Fix the Future program operates with 385 relief veterinarians at just $35 per surgery The power of MASH-style clinics and why community cat advocates should consider creating their own Why Michigan serves as a prime example with 3,000 cats out of 4,000 total surgeries at their clinic The importance of spaying/neutering before adoption and addressing kittens under six months How veterinary school limitations (graduating with only 1-3 spay/neuter surgeries) impact private practice capacity Cathy's honest story about learning from the declawing controversy and how it changed her foundation's policies Practical advice for getting involved at any age and making a difference beyond just donating money The role of Empty the Shelters adoption events in supporting shelter operations nationwide Why every animal deserves vaccination and ear-tipping as part of comprehensive TNR programs Resources mentioned: Bissell Pet Foundation website (https://www.bissellpetfoundation.org/) Empty the Shelters adoption events (https://www.bissellpetfoundation.org/programs/empty-the-shelters/) Fix the Future spay/neuter initiative (https://www.bissellpetfoundation.org/programs/fix-the-future/) Mississippi State University College of Veterinary Medicine (https://www.vetmed.msstate.edu/) MSU shelter medicine program details (https://www.vetmed.msstate.edu/about/points-of-pride) United Spay Alliance website (https://www.unitedspayalliance.org/) United Spay Alliance wet lab training programs (https://www.unitedspayalliance.org/hqhvsn-wet-labs/) BISSELL Pet Foundation grant information (https://www.bissellpetfoundation.org/grant-information/) Operation Fix the Future clinics (https://www.bissellpetfoundation.org/operation-fix-the-future/) BISSELL Pet Foundation Facebook page (https://www.facebook.com/bissellpets/) Sponsor Links: Maddie's Fund (https://www.communitycatspodcast.com/maddies623) Six Degrees of Cats (https://podcasts.apple.com/us/podcast/6-degrees-of-cats/id1669849217) Follow & Review We'd love for you to follow us if you haven't yet. Click that purple '+' in the top right corner of your Apple Podcasts app. We'd love it even more if you could drop a review or 5-star rating over on Apple Podcasts(https://podcasts.apple.com/us/podcast/the-community-cats-podcast/id1125752101?mt=2). Select “Ratings and Reviews” and “Write a Review” then share a quick line with your favorite part of the episode. It only takes a second and it helps spread the word about the podcast.

Send us a message with this link, we would love to hear from you. Standard message rates may apply.The liver performs vital functions including filtering toxins, producing proteins, storing energy, aiding digestion, and regulating cholesterol and hormones. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) has become the most common chronic liver disease globally, affecting up to 38% of the population worldwide.• The liver filters blood, breaks down alcohol and medications, produces proteins like albumin and clotting factors• It stores energy as glycogen, vitamins, and minerals including iron• The liver makes bile for digesting fats and helps regulate cholesterol and support immune function• Common liver problems include fatty liver disease, alcohol use, viral infections, and medication toxicity• MASLD (formerly non-alcoholic fatty liver disease) occurs when too much fat builds up in the liver• MASH is a severe form of MASLD with inflammation and damage that can lead to fibrosis and cirrhosis• Up to 38% of people worldwide have MASLD, with prevalence rising to 65% in those with type 2 diabetes• 5-10% total body weight loss can help slow, stop or reverse liver injury from MASLD• The FDA recently approved semaglutide (Wegovy) as the first specific medication for treating MASH• Regular check-ups with blood tests can help detect liver problems before symptoms developStay healthy, and if you're concerned about your liver health, speak with your healthcare provider about testing and treatment options.Support the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

Did you know that nearly one in three people with obesity may have fatty liver disease without even knowing it? In this episode, I talk about groundbreaking news in obesity and liver health, focusing on the FDA's recent approval of WeGovy to treat metabolic dysfunction associated steatohepatitis (MASH) with moderate to advanced fibrosis. I share a personal story about a friend who once struggled with fatigue, abnormal liver tests, and fatty liver disease, highlighting how limited treatment options used to be. I explain what MASH is, why it's so serious, and how common it is, especially among people with obesity and metabolic syndrome.  Furthermore, I dive into the ESSENCE trial, which showed that WeGovy not only improved liver inflammation and scarring but in some cases even reversed the disease, all while emphasizing that it works best when combined with lifestyle changes like healthy eating and regular activity.  Don't miss this episode where I break down the latest breakthrough in liver and weight loss care that could change your health journey!   Episode Highlights: FDA approval of WeGovy for treating MASH with fibrosis The ESSENCE trial results showing improvements in liver health Understanding what MASH is and why it's so common Importance of combining medication with lifestyle changes Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Audio roundup of selected biopharma industry content from Scrip over the business week ended August 22, 2025. In this episode: Madrigal regains MASH lead with EU Rezdiffra approval; Viking's obesity data scare investors; China assets lead GLP-1 deals; CSL and others restructure; and Indegene exec on DTP and MFN policies. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-T77LV22VANAL5GNPCC2YUVLZBE/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

In this Q&A Mash episode, we answer your burning questions around weight loss resistance, hormone chaos, gut health confusion, and the BS behind one-size-fits-all advice. Liz and Becca dive deep into how context matters more than any single lab result, macro count, or training plan. Inside, we cover: What under-eating really does to your metabolism How overtraining wrecks your hormones Why “normal” labs don't mean jack The #1 mindset shift that moves the needle in healing This episode is your permission slip to stop doing “more” and start doing what's right for your body. *** Get Your Tickets Now: Use code REVIVAL for $100 discount ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠FitMom | UNSTUCK: The Women's Health & Hormone Summit⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ *** Gut & Hormones all messed up? ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠➡️ Take the quiz⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ***

22.08.25 Pt 2 Gareth Cliff and Ben Karpinski dive into a wild story about a woman who celebrated beating cancer by hooking up with 200 men — sparking a broader discussion about the secrets and strange origins of Scientology, from alien myths to modern controversies. Mash joins in with a look at the latest lifestyle buzz around “Ozempic butt,” as well as the dangers of self-driving cars that can unexpectedly grind to a halt in the middle of the road. To end things off on a high note, the team celebrates this week's Beautiful Moment: proudly South African words like “gatvol” officially making their way into the Oxford Dictionary. The Real Network

Hollywood actor Alan Alda has devoted his life to science, by taking his acting and communication skills off the screen and into the laboratory. Alan grew up in a show business family and spent his childhood touring with a burlesque show run by his parents.He eventually made a name for himself in showbiz, becoming well-known and much-loved for his performances in M.A.S.H. and The West Wing, as well as his roles in many Hollywood films.Alan is also famous for his love of science.He wrote Dear Albert for the stage, based on the love letters of Albert Einstein, which reveal Einstein as a beautifully passionate man.Alan has used his acting for the good of science by teaching communication skills to scientists so they might make their work better known and better understood.Further informationThis interview was first broadcast in December 2016.2025 update:  Alan has been diagnosed with Parkinson's disease, but he says he's managing it well.  Alan is still working occasionally, most recently in the TV remake of his 1981 film ‘The Four Seasons'.You can read all about the Conversations origin story on the ABC News website.This episode of Conversations explores science, science communication, MASH, television, Hollywood, silver screen, acting, show biz families, family business, Vietnam, origin stories, memoir.To binge even more great episodes of the Conversations podcast with Richard Fidler and Sarah Kanowski go the ABC listen app (Australia) or wherever you get your podcasts. There you'll find hundreds of the best thought-provoking interviews with authors, writers, artists, politicians, psychologists, musicians, and celebrities.

Alan Alda grew up in a show business family and spent his childhood touring with a burlesque show run by his parents. He eventually made a name for himself in showbiz, becoming well-known and much-loved for his performances in M.A.S.H. and The West Wing, as well as his roles in many Hollywood films.Alan is also famous for his love of science.He wrote Dear Albert for the stage, based on the love letters of Albert Einstein, which reveal Einstein as a beautifully passionate man.Alan has used his acting for the good of science by teaching communication skills to scientists so they might make their work better known and better understood.

Listener questions? We got 'em. Voicemails? We have those, too! In this episode of MASH Matters, Jeff & Ryan knock a few more questions off the top of the overflowing mailbag. Topics range from MASH vodka dispensers and Cincinnati stalkers to the color of Hawkeye's robe and the size of Klinger's nose. We also, at long last, announce the winner of the MASH fan name poll. All this, plus... Igor is a surgeon?!? Support the podcast on Patreon and buy merch at the MASH Matters store For show notes, episodes, recipes, bios, and more visit our website.  

"I was scamming them left and right." Everybody knows that when you stayed home from school you watched Price is Right and rooted for Plinko. Learn more about your ad choices. Visit podcastchoices.com/adchoices